Treating Morbid Extreme Obesity.
A first-of-its-kind teach that curbs the passion by electrically stimulating stomach nerves was approved Wednesday by the US Food and Drug Administration. The Maestro Rechargeable System is intended to touch on disordered (extreme) obesity, tool manufacturer EnteroMedics Inc said in its pertinence for FDA approval. The implant sends electrical signals to nerves around the bear that help control digestion vigrxpills.club. These signals hinder the nerves, decreasing hunger pangs and making the being feel full.
The FDA approved the bearing for use in people 18 and older who have a body-mass index (BMI) of 35 to 45 and at least one other obesity-related condition, such as pattern 2 diabetes. BMI is a relationship that determines body fat based on a person's culmination and weight. For example, a person who's 5 feet, 8 inches unbelievable and weighs 230 pounds has a BMI of 35 learn more. People with a BMI of 30 or higher are considered obese, according to the US Centers for Disease Control and Prevention.
People receiving a Maestro ingraft also must have tried and failed to give the slip preponderance with a old weight loss program, the FDA said. The ruse is the first FDA-approved obesity appliance since 2007. In clinical trials, people with a Maestro insert lost an average 8,5 percent more weight after one year than others who received a charlatan implant. About half of the implanted patients late at least 20 percent of their excess weight, and 38 percent helpless at least 25 percent of their superabundance weight.
EnteroMedics reported that people with fake implants regained about 40 percent of the charge they had lost within six months of the trial's end, while the folk with the Maestro device appeared to tolerate their weight loss. According to the CDC, more than one-third of all US adults are obese, and mortals with obesity are at increased risk of heart disease, stroke, specimen 2 diabetes and certain cancers.
And "Obesity and its coupled medical conditions are major public fitness problems," Dr William Maisel, chief scientist in the FDA's Center for Devices and Radiological Health, said in an intervention gossip release. "Medical devices can help physicians and patients to ripen comprehensive obesity treatment plans". As pull apart of the FDA approval, Minnesota-based EnteroMedics must conduct a five-year post-approval con that will follow at least 100 patients and collect additional protection and effectiveness data.
Показаны сообщения с ярлыком device. Показать все сообщения
Показаны сообщения с ярлыком device. Показать все сообщения
четверг, 2 мая 2019 г.
вторник, 11 декабря 2018 г.
New treatment for migraine
New treatment for migraine.
The US Food and Drug Administration has approved the ahead trade mark aimed at easing the cramp of migraines preceded by aura - sensory disturbances that turn up just before an attack. About a third of migraine sufferers trial auras. The Cerena Transcranial Magnetic Stimulator would be obtained through prescription, the FDA said in a report released Friday Dec, 2013. Patients use both hands to hold the machination against the back of their supreme and press a button so that the device can release a pulse of winning energy herbal. This pulse stimulates the brain's occipital cortex, which may block or ease migraine pain.
And "Millions of kinfolk suffer from migraines, and this new device represents a new care option for some patients," Christy Foreman, director of the Office of Device Evaluation in the FDA's Center for Devices and Radiological Health, said in the statement supplements. The agency's acceptance is based on a pain involving 201 patients who had suffered moderate-to-strong migraine with aura.
The US Food and Drug Administration has approved the ahead trade mark aimed at easing the cramp of migraines preceded by aura - sensory disturbances that turn up just before an attack. About a third of migraine sufferers trial auras. The Cerena Transcranial Magnetic Stimulator would be obtained through prescription, the FDA said in a report released Friday Dec, 2013. Patients use both hands to hold the machination against the back of their supreme and press a button so that the device can release a pulse of winning energy herbal. This pulse stimulates the brain's occipital cortex, which may block or ease migraine pain.
And "Millions of kinfolk suffer from migraines, and this new device represents a new care option for some patients," Christy Foreman, director of the Office of Device Evaluation in the FDA's Center for Devices and Radiological Health, said in the statement supplements. The agency's acceptance is based on a pain involving 201 patients who had suffered moderate-to-strong migraine with aura.
понедельник, 11 апреля 2016 г.
New Methods Of Diagnosis Of Stroke
New Methods Of Diagnosis Of Stroke.
The explication to correctly diagnosing when a protection of dizziness is just giddiness or a life-threatening stroke may be surprisingly simple: a pair of goggles that measures vision movement at the bedside in as little as one minute, a renewed study contends. "This is the first study demonstrating that we can accurately be intolerant strokes and non-strokes using this device," said Dr David Newman-Toker, pattern author of a paper on the technique that is published in the April dissemination of the journal Stroke problem-solutions.com. Some 100000 strokes are misdiagnosed as something else each year in the United States, resulting in 20000 to 30000 deaths or painstaking true and speech impairments, the researchers said.
As with quintessence attacks, the key to treating movement and potentially saving a person's life is speed. Magnetic resonance imaging (MRI), the progress gold standard for assessing stroke, can put into effect up to six hours to complete and costs $1200, said Newman-Toker, who is an associated professor of neurology and otolaryngology at Johns Hopkins Hospital in Baltimore worldedhelp.com. Sometimes living souls don't even get as far as an MRI, and may be sent nursing home with a first "mini stroke" that is followed by a penetrating second stroke.
The new study findings come with some significant caveats, however. For one thing, the observe was a small one, involving only 12 patients. "It is hopeless for a small study to end up 100 percent accuracy," said Dr Daniel Labovitz, manager of the Stern Stroke Center at Montefiore Medical Center in New York City, who was not active with the study. About 4 percent of dizziness cases in the difficulty allowance are caused by stroke.
The other caveat is that the device is not yet approved in the United States for diagnosing stroke. The US Food and Drug Administration only recently gave it sanction for use in assessing balance. It has been handy in Europe for that intent for about a year. The device - known as a video-oculography automobile - is a modification of a "head impulse test," which is utilized regularly for people with chronic dizziness and other inner ear-balance disorders.
The explication to correctly diagnosing when a protection of dizziness is just giddiness or a life-threatening stroke may be surprisingly simple: a pair of goggles that measures vision movement at the bedside in as little as one minute, a renewed study contends. "This is the first study demonstrating that we can accurately be intolerant strokes and non-strokes using this device," said Dr David Newman-Toker, pattern author of a paper on the technique that is published in the April dissemination of the journal Stroke problem-solutions.com. Some 100000 strokes are misdiagnosed as something else each year in the United States, resulting in 20000 to 30000 deaths or painstaking true and speech impairments, the researchers said.
As with quintessence attacks, the key to treating movement and potentially saving a person's life is speed. Magnetic resonance imaging (MRI), the progress gold standard for assessing stroke, can put into effect up to six hours to complete and costs $1200, said Newman-Toker, who is an associated professor of neurology and otolaryngology at Johns Hopkins Hospital in Baltimore worldedhelp.com. Sometimes living souls don't even get as far as an MRI, and may be sent nursing home with a first "mini stroke" that is followed by a penetrating second stroke.
The new study findings come with some significant caveats, however. For one thing, the observe was a small one, involving only 12 patients. "It is hopeless for a small study to end up 100 percent accuracy," said Dr Daniel Labovitz, manager of the Stern Stroke Center at Montefiore Medical Center in New York City, who was not active with the study. About 4 percent of dizziness cases in the difficulty allowance are caused by stroke.
The other caveat is that the device is not yet approved in the United States for diagnosing stroke. The US Food and Drug Administration only recently gave it sanction for use in assessing balance. It has been handy in Europe for that intent for about a year. The device - known as a video-oculography automobile - is a modification of a "head impulse test," which is utilized regularly for people with chronic dizziness and other inner ear-balance disorders.
вторник, 29 апреля 2014 г.
More Than 250000 People Die Each Year From Heart Failure In The United States
More Than 250000 People Die Each Year From Heart Failure In The United States.
To modernize the excellence of lifesaving devices called automated superficial defibrillators, the US Food and Drug Administration proposed Friday that the seven manufacturers of these devices be required to get intervention green light for their products. Automated visible defibrillators (AEDs) are pocket-sized devices that deliver an electrical shock to the nitty-gritty to try to restore normal heart rhythms during cardiac arrest your vito. Although the FDA is not recalling AEDs, the intermediation said that it is troubled with the number of recalls and quality problems associated with them.
And "The FDA is not questioning the clinical utility of AEDs," Dr William Maisel, chieftain scientist in FDA's Center for Devices and Radiological Health, said during a gathering discussion on Friday announcing the proposal. "These devices are critically high-level and go through a very important public health need neartohealth.com. The prominence of early defibrillation for patients who are suffering from cardiac arrest is well-established," he said.
Maisel added the FDA is not occupation into question the safety or attribute of AEDs currently in place around the country. There are about 2,4 million such devices in general places throughout the United States, according to The New York Times. "Today's exertion does not require the house-moving or replacement of AEDs that are in distribution. Patients and the public should have aplomb in these devices, and we encourage people to use them under the appropriate circumstances," Maisel said.
Although there have been problems with AEDs, their lifesaving benefits tip the scales the risk of making them unavailable, Maisel explained. Dr Moshe Gunsburg, steersman of cardiac arrhythmia appointment and co-chief of the division of cardiology at Brookdale University Hospital and Medical Center in Brooklyn, NY, supports the FDA proposal. "Cardiac nick is the unequalled cause of extermination in the United States.
It claims over 250000 lives a year," he said. Early defibrillation is the skeleton key to helping patients survive, Gunsburg said. Timing, however, is critical. If a tireless is not defibrillated within four to six minutes, intellect cost starts and the odds of survival diminish with each passing minute, which is why 90 percent of these patients don't survive, he explained.
The best unforeseen a unwavering has is an automated external defibrillator used quickly, which is why Gunsburg and others want AEDs to be as plain as fire extinguishers so laypeople can use them when they find out someone go into cardiac arrest. The FDA's exercise will help ensure that these devices are in top shape when they are needed, he said.
To modernize the excellence of lifesaving devices called automated superficial defibrillators, the US Food and Drug Administration proposed Friday that the seven manufacturers of these devices be required to get intervention green light for their products. Automated visible defibrillators (AEDs) are pocket-sized devices that deliver an electrical shock to the nitty-gritty to try to restore normal heart rhythms during cardiac arrest your vito. Although the FDA is not recalling AEDs, the intermediation said that it is troubled with the number of recalls and quality problems associated with them.
And "The FDA is not questioning the clinical utility of AEDs," Dr William Maisel, chieftain scientist in FDA's Center for Devices and Radiological Health, said during a gathering discussion on Friday announcing the proposal. "These devices are critically high-level and go through a very important public health need neartohealth.com. The prominence of early defibrillation for patients who are suffering from cardiac arrest is well-established," he said.
Maisel added the FDA is not occupation into question the safety or attribute of AEDs currently in place around the country. There are about 2,4 million such devices in general places throughout the United States, according to The New York Times. "Today's exertion does not require the house-moving or replacement of AEDs that are in distribution. Patients and the public should have aplomb in these devices, and we encourage people to use them under the appropriate circumstances," Maisel said.
Although there have been problems with AEDs, their lifesaving benefits tip the scales the risk of making them unavailable, Maisel explained. Dr Moshe Gunsburg, steersman of cardiac arrhythmia appointment and co-chief of the division of cardiology at Brookdale University Hospital and Medical Center in Brooklyn, NY, supports the FDA proposal. "Cardiac nick is the unequalled cause of extermination in the United States.
It claims over 250000 lives a year," he said. Early defibrillation is the skeleton key to helping patients survive, Gunsburg said. Timing, however, is critical. If a tireless is not defibrillated within four to six minutes, intellect cost starts and the odds of survival diminish with each passing minute, which is why 90 percent of these patients don't survive, he explained.
The best unforeseen a unwavering has is an automated external defibrillator used quickly, which is why Gunsburg and others want AEDs to be as plain as fire extinguishers so laypeople can use them when they find out someone go into cardiac arrest. The FDA's exercise will help ensure that these devices are in top shape when they are needed, he said.
пятница, 17 января 2014 г.
FDA Will Strengthen The Supervision Of Used Home Medical Equipment
FDA Will Strengthen The Supervision Of Used Home Medical Equipment.
As the inhabitants ages and medical technology improves, more grass roots are using complex medical devices such as dialysis machines and ventilators at home, adding to the essential for better-educated patients buyrxworld.com. To join this growing need, the US Food and Drug Administration announced Tuesday that it has started a unheard of program to secure that patients and their caregivers use these devices safely and effectively.
So "Medical thingumajig digs use is becoming an increasingly noteworthy public health issue," Dr Jeffrey Shuren, leader of the FDA's Center for Devices and Radiological Health said during an afternoon message conference. The US population is aging, and more persons are living longer with chronic diseases that be short home care, he added active. "In addition, more patients of all ages are being discharged from the sanatorium to continue their care at home," Shuren noted.
Meanwhile, medical devices have become more light and sophisticated, making it viable to treat and monitor chronic conditions outside the hospital. "A significant crowd of devices including infusion pumps, ventilators and torment care therapies are now being used for home care," he said.
Given the growing host of home medical devices, the agency plans on developing procedures for makers of home-care equipment. Procedures will subsume post-marketing follow-up, and other things that will foster the safe use of these devices. The FDA is also developing revelatory materials on the safe use of these devices, the activity said.
As the inhabitants ages and medical technology improves, more grass roots are using complex medical devices such as dialysis machines and ventilators at home, adding to the essential for better-educated patients buyrxworld.com. To join this growing need, the US Food and Drug Administration announced Tuesday that it has started a unheard of program to secure that patients and their caregivers use these devices safely and effectively.
So "Medical thingumajig digs use is becoming an increasingly noteworthy public health issue," Dr Jeffrey Shuren, leader of the FDA's Center for Devices and Radiological Health said during an afternoon message conference. The US population is aging, and more persons are living longer with chronic diseases that be short home care, he added active. "In addition, more patients of all ages are being discharged from the sanatorium to continue their care at home," Shuren noted.
Meanwhile, medical devices have become more light and sophisticated, making it viable to treat and monitor chronic conditions outside the hospital. "A significant crowd of devices including infusion pumps, ventilators and torment care therapies are now being used for home care," he said.
Given the growing host of home medical devices, the agency plans on developing procedures for makers of home-care equipment. Procedures will subsume post-marketing follow-up, and other things that will foster the safe use of these devices. The FDA is also developing revelatory materials on the safe use of these devices, the activity said.
Подписаться на:
Комментарии (Atom)